May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Moleculargenetic Findings and Therapeutical Options in a Well Examined German Family With Macular Corneal Dystrophy
Author Affiliations & Notes
  • C. Gruenauer–Kloevekorn
    Dep. of Ophthalmology, University of Halle, Halle, Germany
  • S. Braeutigam
    Institute of Human Genetics, Fac. of Medicine, University of Leipzig, Leipzig, Germany
  • U. Froster
    Institute of Human Genetics, Fac. of Medicine, University of Leipzig, Leipzig, Germany
  • G.I. W. Duncker
    Dep. of Ophthalmology, University of Halle, Halle, Germany
  • Footnotes
    Commercial Relationships  C. Gruenauer–Kloevekorn, None; S. Braeutigam, None; U. Froster, None; G.I.W. Duncker, None.
  • Footnotes
    Support  European social fond
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4931. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. Gruenauer–Kloevekorn, S. Braeutigam, U. Froster, G.I. W. Duncker; Moleculargenetic Findings and Therapeutical Options in a Well Examined German Family With Macular Corneal Dystrophy . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4931.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Mutations in the carbohydrate sulfotransferase 6 gene (CHST6) were identified to cause the autosomal recessive macular corneal dystrophy type I (MCD). We report on the moleculargenetic findings and early intervention with phototherapeutic keratectomy for treatment of macular corneal dystrophy in a well examined German family. Methods: Genomic DNA was extracted from the leucocytes in the peripherial blood of two affected sisters, their nonaffected parents and their nonaffected brother . The coding region of CHST6 was examined for mutations by polymerase chain reaction and direkt sequencing. Both sisters underwent phototherapeutic keratectomy in both eyes because of progredient corneal opacities and decreased visual acuity. Results: Both sisters were homozygous for a novel missense mutation A–>T in nucleotid 181 of the CHST6 gene wich results in a homozygous amino acid translation Met1Leu in the start codon of the CHST6 gene in both sisters. All of the nonaffected examined family members had a heterozygous missense mutation A–>T in nucleotid 181 of the CHST6 gene. Uncorrected visual acuity of both sisters improved from a mean of 0.25 to a mean of 0.64. After a follow up of 9 months there has been no anterior recurrence, no haze and no complications. Conclusions: Missense mutation in the CHST6 start codon leeds to a relative mild form of MCD type I wich can successfully treated with phototherapeutic keratectomy. Early intervention is relatively safe and preferable to observation or penetrating keratoplasty.

Keywords: cornea: clinical science • genetics • laser 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×